Cargando…

Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development

The neurological complications of infection by the mosquito-borne Zika virus (ZIKV) include Guillain–Barré syndrome (GBS), an acute inflammatory demyelinating polyneuritis. GBS was first associated with recent ZIKV epidemics caused by the emergence of the ZIKV Asian lineage in South Pacific. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebeau, Grégorie, Frumence, Etienne, Turpin, Jonathan, Begue, Floran, Hoarau, Jean-Jacques, Gadea, Gilles, Krejbich-Trotot, Pascale, Desprès, Philippe, Viranaicken, Wildriss
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003386/
https://www.ncbi.nlm.nih.gov/pubmed/33808706
http://dx.doi.org/10.3390/vaccines9030283
_version_ 1783671677479026688
author Lebeau, Grégorie
Frumence, Etienne
Turpin, Jonathan
Begue, Floran
Hoarau, Jean-Jacques
Gadea, Gilles
Krejbich-Trotot, Pascale
Desprès, Philippe
Viranaicken, Wildriss
author_facet Lebeau, Grégorie
Frumence, Etienne
Turpin, Jonathan
Begue, Floran
Hoarau, Jean-Jacques
Gadea, Gilles
Krejbich-Trotot, Pascale
Desprès, Philippe
Viranaicken, Wildriss
author_sort Lebeau, Grégorie
collection PubMed
description The neurological complications of infection by the mosquito-borne Zika virus (ZIKV) include Guillain–Barré syndrome (GBS), an acute inflammatory demyelinating polyneuritis. GBS was first associated with recent ZIKV epidemics caused by the emergence of the ZIKV Asian lineage in South Pacific. Here, we hypothesize that ZIKV-associated GBS relates to a molecular mimicry between viral envelope E (E) protein and neural proteins involved in GBS. The analysis of the ZIKV epidemic strains showed that the glycan loop (GL) region of the E protein includes an IVNDT motif which is conserved in voltage-dependent L-type calcium channel subunit alpha-1C (Ca(v)1.2) and Heat Shock 70 kDa protein 12A (HSP70 12A). Both VSCC-alpha 1C and HSP70 12A belong to protein families which have been associated with neurological autoimmune diseases in central nervous system. The purpose of our in silico analysis is to point out that IVNDT motif of ZIKV E-GL region should be taken in consideration for the development of safe and effective anti-Zika vaccines by precluding the possibility of adverse neurologic events including autoimmune diseases such as GBS through a potent mimicry with Heat Shock 70 kDa protein 12A (HSP70 12A).
format Online
Article
Text
id pubmed-8003386
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80033862021-03-28 Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development Lebeau, Grégorie Frumence, Etienne Turpin, Jonathan Begue, Floran Hoarau, Jean-Jacques Gadea, Gilles Krejbich-Trotot, Pascale Desprès, Philippe Viranaicken, Wildriss Vaccines (Basel) Brief Report The neurological complications of infection by the mosquito-borne Zika virus (ZIKV) include Guillain–Barré syndrome (GBS), an acute inflammatory demyelinating polyneuritis. GBS was first associated with recent ZIKV epidemics caused by the emergence of the ZIKV Asian lineage in South Pacific. Here, we hypothesize that ZIKV-associated GBS relates to a molecular mimicry between viral envelope E (E) protein and neural proteins involved in GBS. The analysis of the ZIKV epidemic strains showed that the glycan loop (GL) region of the E protein includes an IVNDT motif which is conserved in voltage-dependent L-type calcium channel subunit alpha-1C (Ca(v)1.2) and Heat Shock 70 kDa protein 12A (HSP70 12A). Both VSCC-alpha 1C and HSP70 12A belong to protein families which have been associated with neurological autoimmune diseases in central nervous system. The purpose of our in silico analysis is to point out that IVNDT motif of ZIKV E-GL region should be taken in consideration for the development of safe and effective anti-Zika vaccines by precluding the possibility of adverse neurologic events including autoimmune diseases such as GBS through a potent mimicry with Heat Shock 70 kDa protein 12A (HSP70 12A). MDPI 2021-03-19 /pmc/articles/PMC8003386/ /pubmed/33808706 http://dx.doi.org/10.3390/vaccines9030283 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Brief Report
Lebeau, Grégorie
Frumence, Etienne
Turpin, Jonathan
Begue, Floran
Hoarau, Jean-Jacques
Gadea, Gilles
Krejbich-Trotot, Pascale
Desprès, Philippe
Viranaicken, Wildriss
Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development
title Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development
title_full Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development
title_fullStr Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development
title_full_unstemmed Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development
title_short Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development
title_sort zika e glycan loop region and guillain–barré syndrome-related proteins: a possible molecular mimicry to be taken in account for vaccine development
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003386/
https://www.ncbi.nlm.nih.gov/pubmed/33808706
http://dx.doi.org/10.3390/vaccines9030283
work_keys_str_mv AT lebeaugregorie zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment
AT frumenceetienne zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment
AT turpinjonathan zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment
AT beguefloran zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment
AT hoaraujeanjacques zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment
AT gadeagilles zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment
AT krejbichtrototpascale zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment
AT despresphilippe zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment
AT viranaickenwildriss zikaeglycanloopregionandguillainbarresyndromerelatedproteinsapossiblemolecularmimicrytobetakeninaccountforvaccinedevelopment